{"ticker": "BIOE", "overview": {"cik": "1723059", "ticker": "BIOE", "name": "Bio Essence Corp", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "4/A", "date": "2026-10-14", "title": "Form 4/A", "accession": "0001213900-26-109431", "price_sensitive": false}, {"form": "144", "date": "2026-10-13", "title": "Notice of proposed sale", "accession": "0001213900-26-108646", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "QUARTERLY REPORT", "accession": "0001213900-26-090174", "price_sensitive": true}, {"form": "8-K/A", "date": "2026-05-19", "title": "AMENDMENT NO. 1 TO FORM 8-K", "accession": "0001213900-26-058985", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-15", "title": "QUARTERLY REPORT", "accession": "0001213900-26-057529", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-24", "title": "CURRENT REPORT", "accession": "0001213900-26-047207", "price_sensitive": true}, {"form": "10-K", "date": "2026-03-27", "title": "ANNUAL REPORT", "accession": "0001213900-26-035467", "price_sensitive": true}, {"form": "QUALIF", "date": "2026-01-05", "title": "Form QUALIF", "accession": "9999999994-26-000004", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-12", "title": "QUARTERLY REPORT", "accession": "0001213900-25-108357", "price_sensitive": true}, {"form": "1-A", "date": "2025-10-17", "title": "Form 1-A", "accession": "0001213900-25-100050", "price_sensitive": false}, {"form": "10-Q", "date": "2025-08-14", "title": "QUARTERLY REPORT", "accession": "0001213900-25-076353", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-15", "title": "QUARTERLY REPORT", "accession": "0001213900-25-043524", "price_sensitive": true}, {"form": "10-K", "date": "2025-03-28", "title": "ANNUAL REPORT", "accession": "0001013762-25-003850", "price_sensitive": true}, {"form": "UPLOAD", "date": "2024-12-05", "title": "Form UPLOAD", "accession": "0000000000-24-013393", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-11-27", "title": "AMENDMENT NO. 3 TO FORM 10-Q", "accession": "0001213900-24-103410", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-11-27", "title": "AMENDMENT NO. 3 TO FORM 10-Q", "accession": "0001213900-24-103408", "price_sensitive": false}, {"form": "4", "date": "2024-11-18", "title": "Insider transaction", "accession": "0001213900-24-099693", "price_sensitive": false}, {"form": "10-Q", "date": "2024-11-14", "title": "QUARTERLY REPORT", "accession": "0001213900-24-098180", "price_sensitive": true}, {"form": "UPLOAD", "date": "2024-11-08", "title": "Form UPLOAD", "accession": "0000000000-24-012471", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-10-30", "title": "AMENDMENT NO. 2 TO FORM 10-Q", "accession": "0001213900-24-091885", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-10-30", "title": "AMENDMENT NO. 2 TO FORM 10-Q", "accession": "0001213900-24-091884", "price_sensitive": false}, {"form": "UPLOAD", "date": "2024-10-21", "title": "Form UPLOAD", "accession": "0000000000-24-011777", "price_sensitive": false}, {"form": "4/A", "date": "2024-10-11", "title": "Form 4/A", "accession": "0001213900-24-087183", "price_sensitive": false}, {"form": "4", "date": "2024-10-10", "title": "Insider transaction", "accession": "0001213900-24-087036", "price_sensitive": false}, {"form": "4/A", "date": "2024-10-10", "title": "Form 4/A", "accession": "0001213900-24-086923", "price_sensitive": false}]}, "description": "Bio Essence Corp trades as BIOE and is registered in the United States, classified under Pharmaceutical Preparations (SIC 2834). Privy Trades holds 7 insider filings for the company, from June 2023 to October 2024. Across those, 1 insider disclosed 2 open-market purchases totalling $5.00M against 5 sales totalling $3.41M. The most recent filing on record is dated 30 October 2024.", "exchange": null, "stats": {"buy_n": 2, "buy_sum": 5000000.0, "sell_n": 5, "sell_sum": 3409133.009, "net": 1590866.991, "insiders": 1, "first_date": "2023-06-06", "last_date": "2024-10-30"}, "metrics": {"ticker": "BIOE", "has_prices": false}, "trades": [{"id": "0001213900-26-109431", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 432043.65, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The corner office trims BIOE: $432K", "source_url": "https://www.sec.gov/Archives/edgar/data/1990397/000121390026109431/0001213900-26-109431-index.htm", "trade_date": "2024-10-30", "timestamp": "2024-10-30", "mins": 1056409}, {"id": "0001213900-24-099693", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 455191.65, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO sells $455K of BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024099693/0001213900-24-099693-index.htm", "trade_date": "2024-10-30", "timestamp": "2024-10-30", "mins": 1056409}, {"id": "0001213900-24-087036", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 106814.5, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO sells $107K of BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024087036/0001213900-24-087036-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099609}, {"id": "0001213900-24-062097", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 484286.109, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO offloads $484K of BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024062097/0001213900-24-062097-index.htm", "trade_date": "2024-07-05", "timestamp": "2024-07-05", "mins": 1224889}, {"id": "0001213900-24-086923", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "SELL", "amount": 1930797.1, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO offloads $1.9M of BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024086923/0001213900-24-086923-index.htm", "trade_date": "2024-07-05", "timestamp": "2024-07-05", "mins": 1224889}, {"id": "0001213900-24-049108", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 2500000.0, "score": 71.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO loads up: $2.5M into BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024049108/0001213900-24-049108-index.htm", "trade_date": "2023-06-06", "timestamp": "2023-06-06", "mins": 1793689}, {"id": "0001213900-24-087183", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 2500000.0, "score": 74.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO loads up: $2.5M into BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024087183/0001213900-24-087183-index.htm", "trade_date": "2023-06-06", "timestamp": "2023-06-06", "mins": 1793689}], "recent_buys": [{"id": "0001213900-24-087183", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 2500000.0, "score": 74.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO loads up: $2.5M into BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024087183/0001213900-24-087183-index.htm", "trade_date": "2023-06-06", "timestamp": "2023-06-06", "mins": 1793689}, {"id": "0001213900-24-049108", "src": "INSIDERS", "ticker": "BIOE", "cik": "1723059", "company": "Bio Essence Corp", "company_raw": "Bio Essence Corp", "who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 2500000.0, "score": 71.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO loads up: $2.5M into BIOE", "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024049108/0001213900-24-049108-index.htm", "trade_date": "2023-06-06", "timestamp": "2023-06-06", "mins": 1793689}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "No longer listed", "items": [{"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "BIOE", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.853130"}]}, "key_people": [{"who": "Yin Yan", "who_key": "Yan Yin", "role": "Chief Executive Officer, Director, 10% Owner", "person_type": "CEO", "person_label": "CEOs", "bought": 5000000.0, "sold": 3409133.009, "net": 1590866.991, "trades": 7, "top_score": 74.1, "lean": "buying", "history": [{"action": "SELL", "amount": 432043.65, "date": "2024-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1990397/000121390026109431/0001213900-26-109431-index.htm"}, {"action": "SELL", "amount": 455191.65, "date": "2024-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024099693/0001213900-24-099693-index.htm"}, {"action": "SELL", "amount": 106814.5, "date": "2024-09-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024087036/0001213900-24-087036-index.htm"}, {"action": "SELL", "amount": 484286.109, "date": "2024-07-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024062097/0001213900-24-062097-index.htm"}, {"action": "SELL", "amount": 1930797.1, "date": "2024-07-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024086923/0001213900-24-086923-index.htm"}, {"action": "BUY", "amount": 2500000.0, "date": "2023-06-06", "score": 71.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024049108/0001213900-24-049108-index.htm"}, {"action": "BUY", "amount": 2500000.0, "date": "2023-06-06", "score": 74.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1723059/000121390024087183/0001213900-24-087183-index.htm"}], "latest": {"action": "SELL", "amount": 432043.65, "date": "2024-10-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1990397/000121390026109431/0001213900-26-109431-index.htm"}}], "activity": [], "announcements": [{"form": "4/A", "date": "2026-10-14", "title": "Form 4/A", "accession": "0001213900-26-109431", "price_sensitive": false}, {"form": "144", "date": "2026-10-13", "title": "Notice of proposed sale", "accession": "0001213900-26-108646", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "QUARTERLY REPORT", "accession": "0001213900-26-090174", "price_sensitive": true}, {"form": "8-K/A", "date": "2026-05-19", "title": "AMENDMENT NO. 1 TO FORM 8-K", "accession": "0001213900-26-058985", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-15", "title": "QUARTERLY REPORT", "accession": "0001213900-26-057529", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-24", "title": "CURRENT REPORT", "accession": "0001213900-26-047207", "price_sensitive": true}, {"form": "10-K", "date": "2026-03-27", "title": "ANNUAL REPORT", "accession": "0001213900-26-035467", "price_sensitive": true}, {"form": "QUALIF", "date": "2026-01-05", "title": "Form QUALIF", "accession": "9999999994-26-000004", "price_sensitive": false}, {"form": "10-Q", "date": "2025-11-12", "title": "QUARTERLY REPORT", "accession": "0001213900-25-108357", "price_sensitive": true}, {"form": "1-A", "date": "2025-10-17", "title": "Form 1-A", "accession": "0001213900-25-100050", "price_sensitive": false}, {"form": "10-Q", "date": "2025-08-14", "title": "QUARTERLY REPORT", "accession": "0001213900-25-076353", "price_sensitive": true}, {"form": "10-Q", "date": "2025-05-15", "title": "QUARTERLY REPORT", "accession": "0001213900-25-043524", "price_sensitive": true}, {"form": "10-K", "date": "2025-03-28", "title": "ANNUAL REPORT", "accession": "0001013762-25-003850", "price_sensitive": true}, {"form": "UPLOAD", "date": "2024-12-05", "title": "Form UPLOAD", "accession": "0000000000-24-013393", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-11-27", "title": "AMENDMENT NO. 3 TO FORM 10-Q", "accession": "0001213900-24-103410", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-11-27", "title": "AMENDMENT NO. 3 TO FORM 10-Q", "accession": "0001213900-24-103408", "price_sensitive": false}, {"form": "4", "date": "2024-11-18", "title": "Insider transaction", "accession": "0001213900-24-099693", "price_sensitive": false}, {"form": "10-Q", "date": "2024-11-14", "title": "QUARTERLY REPORT", "accession": "0001213900-24-098180", "price_sensitive": true}, {"form": "UPLOAD", "date": "2024-11-08", "title": "Form UPLOAD", "accession": "0000000000-24-012471", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-10-30", "title": "AMENDMENT NO. 2 TO FORM 10-Q", "accession": "0001213900-24-091885", "price_sensitive": false}, {"form": "10-Q/A", "date": "2024-10-30", "title": "AMENDMENT NO. 2 TO FORM 10-Q", "accession": "0001213900-24-091884", "price_sensitive": false}, {"form": "UPLOAD", "date": "2024-10-21", "title": "Form UPLOAD", "accession": "0000000000-24-011777", "price_sensitive": false}, {"form": "4/A", "date": "2024-10-11", "title": "Form 4/A", "accession": "0001213900-24-087183", "price_sensitive": false}, {"form": "4", "date": "2024-10-10", "title": "Insider transaction", "accession": "0001213900-24-087036", "price_sensitive": false}, {"form": "4/A", "date": "2024-10-10", "title": "Form 4/A", "accession": "0001213900-24-086923", "price_sensitive": false}], "performance": {"ticker": "BIOE", "has_prices": false, "summary": null, "buys": [{"who": "Yan Yin", "person_type": "CEO", "person_label": "CEOs", "role": "Chief Executive Officer, Director, 10% Owner", "amount": 2500000.0, "date": "2023-06-06", "score": 74.1, "ref_price": null, "return": null}, {"who": "Yan Yin", "person_type": "CEO", "person_label": "CEOs", "role": "Chief Executive Officer, Director, 10% Owner", "amount": 2500000.0, "date": "2023-06-06", "score": 71.1, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}